↓ Skip to main content
What is this page? Embed badge

Phase Ib study of codrituzumab in combination with sorafenib in patients with non-curable advanced hepatocellular carcinoma (HCC)

Overview of attention for article published in Cancer Chemotherapy and Pharmacology, January 2017
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (77th percentile)
  • High Attention Score compared to outputs of the same age and source (81st percentile)

Mentioned by

twitter
1 X user
patent
2 patents
facebook
1 Facebook page

Citations

dimensions_citation
20 Dimensions

Readers on

mendeley
37 Mendeley
Summary X Patents Facebook Dimensions citations
So far, Altmetric has seen 2 patents that reference this research output.

This page is provided by Altmetric.